Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MYCBP associated protein (MYCBPAP) is an intracellular protein predominantly expressed in the testis, where it plays a role in spermatogenesis. It is a binding partner of the c-Myc binding protein AMY-1 and is thought to modulate c-Myc–dependent transcriptional regulation during sperm development. The protein is localized in the cytoplasm and possibly mitochondria, may participate in the regulation of synaptic processes, and is predicted to have molecular functions including clathrin binding, phospholipid binding, and protein binding. Genetic variants in MYCBPAP have been associated with certain forms of male infertility, particularly asthenoteratozoospermia, but no direct therapeutic targeting or biomarker applications are established to date.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MYCBP associated protein (MYCBPAP).